Congress-ESC
Congress-ESC-Mobile

Cardiovascular (CV)

European Society of Cardiology (ESC) 2025

Congress Details

calanderAugust 29 - September 1, 2025

locationMadrid, Spain

The material below is provided to support scientific exchange and pertains to select congress resources. Any content about investigational therapeutics or investigational uses of locally approved products does not establish the safety or efficacy of these therapeutics or uses, and there is no guarantee of local regulatory approval.

All congress materials are copyrighted by Alnylam. Permission is required to copy or distribute.

For questions beyond a product’s authorized indications or for information not available here, please contact Alnylam Medical Information.

Image
Oral

Congress Materials

Image
icon Presentation Type
Presentation
Image
location icon Location
Madrid, Spain
Image
icon Title
KARDIA-3: zilebesiran as add-on therapy in adults with hypertension who have established cardiovascular disease or are at high cardiovascular risk
Image
icon Presentation Type
Poster
Image
location icon Location
Madrid, Spain
Image
icon Title
Impact of Zilebesiran, an Investigational RNA Interference Therapeutic Targeting Hepatic Angiotensinogen, on Renin–Angiotensin System Biomarkers in Patients with Mild-to-Moderate Hypertension